These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15683716)

  • 21. p38 MAPK inhibits JNK2 and mediates cytokine-activated iNOS induction and apoptosis independently of NF-KB translocation in insulin-producing cells.
    Saldeen J; Welsh N
    Eur Cytokine Netw; 2004; 15(1):47-52. PubMed ID: 15217752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord.
    Sung CS; Wen ZH; Chang WK; Chan KH; Ho ST; Tsai SK; Chang YC; Wong CS
    J Neurochem; 2005 Aug; 94(3):742-52. PubMed ID: 16033422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of interleukin-1beta-induced iNOS expression in cultured vascular smooth muscle cells of Goto-Kakizaki diabetes rats.
    Wakabayashi I; Nakano T; Takahashi Y
    Eur J Pharmacol; 2010 Mar; 629(1-3):1-6. PubMed ID: 19958762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaB-mediated gene expression in insulin-producing INS-1E cells.
    Larsen L; Størling J; Darville M; Eizirik DL; Bonny C; Billestrup N; Mandrup-Poulsen T
    Diabetologia; 2005 Dec; 48(12):2582-90. PubMed ID: 16283237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation.
    Zheng GM; Yu C; Yang Z
    Int J Oncol; 2012 May; 40(5):1610-8. PubMed ID: 22246431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
    Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
    Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
    J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.
    Pingle SC; Sanchez JF; Hallam DM; Williamson AL; Maggirwar SB; Ramkumar V
    Mol Pharmacol; 2003 Jun; 63(6):1238-47. PubMed ID: 12761333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes.
    Harbrecht BG; Taylor BS; Xu Z; Ramalakshmi S; Ganster RW; Geller DA
    J Surg Res; 2001 Aug; 99(2):258-64. PubMed ID: 11469895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2.
    Welch GN; Upchurch GR; Farivar RS; Pigazzi A; Vu K; Brecher P; Keaney JF; Loscalzo J
    Proc Assoc Am Physicians; 1998; 110(1):22-31. PubMed ID: 9460080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
    Weber AA; Seul C; Harth V; Ko Y; Seewald S; Vetter H; Sachinidis A
    Br J Pharmacol; 1998 Mar; 123(5):906-10. PubMed ID: 9535019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
    Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
    Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
    Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
    Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma.
    Pawate S; Shen Q; Fan F; Bhat NR
    J Neurosci Res; 2004 Aug; 77(4):540-51. PubMed ID: 15264224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages.
    Han YJ; Kwon YG; Chung HT; Lee SK; Simmons RL; Billiar TR; Kim YM
    Nitric Oxide; 2001; 5(5):504-13. PubMed ID: 11587565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study.
    Adams V; Nehrhoff B; Späte U; Linke A; Schulze PC; Baur A; Gielen S; Hambrecht R; Schuler G
    Cardiovasc Res; 2002 Apr; 54(1):95-104. PubMed ID: 12062366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins.
    Durante W; Kroll MH; Orloff GJ; Cunningham JM; Scott-Burden T; Vanhoutte PM; Schafer AI
    Biochem Pharmacol; 1996 Mar; 51(6):847-53. PubMed ID: 8602881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle.
    Kessler P; Kronemann N; Hecker M; Busse R; Schini-Kerth VB
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):802-10. PubMed ID: 9436821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
    Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
    Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.
    Zhong HM; Ding QH; Chen WP; Luo RB
    Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.